- Home
- NVO vs TD Comparison
NVO vs TD Comparison
Compare NVO & TD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | TD |
|---|---|---|
| Founded | 1923 | 1855 |
| Country | Denmark | Canada |
| Employees | 69500 | 70000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.9B | 197.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVO | TD |
|---|---|---|
| Price | $51.34 | $123.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 1 |
| Target Price | $51.00 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 9.1M | 2.3M |
| Earning Date | 05-06-2026 | 05-21-2026 |
| Dividend Yield | ★ 3.19% | 2.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.70 | $4.48 |
| P/E Ratio | $13.60 | ★ $11.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.12 | $72.21 |
| 52 Week High | $71.80 | $124.84 |
Technical Indicators
Market Signals| Indicator | NVO | TD |
|---|---|---|
| Relative Strength Index (RSI) | 70.43 | 64.21 |
| Support Level | $50.55 | $117.31 |
| Resistance Level | $53.63 | N/A |
| Average True Range (ATR) | 1.04 | 2.03 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 93.72 | 81.88 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets by the end of April 2026. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market shares in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.